Contribution of increased oral bioavailability and reduced nonglomerular renal clearance of digoxin to the digoxin-clarithromycin interaction
A clinically important interaction between the cardiac glycoside digoxin and the antibiotic clarithromycin has been suggested in earlier reports. The aim of this study was to investigate the extent of the interaction and the relative contribution of different mechanisms.
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2003
|
| In: |
British journal of clinical pharmacology
Year: 2003, Jahrgang: 56, Heft: 1, Pages: 32-38 |
| ISSN: | 1365-2125 |
| DOI: | 10.1046/j.1365-2125.2003.01824.x |
| Online-Zugang: | Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1046/j.1365-2125.2003.01824.x Verlag, lizenzpflichtig, Volltext: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1884337/ |
| Verfasserangaben: | Jens Rengelshausen, Christoph Göggelmann, Jürgen Burhenne, Klaus-Dieter Riedel, Jochen Ludwig, Johanna Weiss, Gerd Mikus, Ingeborg Walter-Sack & Walter E Haefeli |
| Zusammenfassung: | A clinically important interaction between the cardiac glycoside digoxin and the antibiotic clarithromycin has been suggested in earlier reports. The aim of this study was to investigate the extent of the interaction and the relative contribution of different mechanisms. |
|---|---|
| Beschreibung: | Gesehen am 17.08.2021 |
| Beschreibung: | Online Resource |
| ISSN: | 1365-2125 |
| DOI: | 10.1046/j.1365-2125.2003.01824.x |